Sansure Biotech Inc.

Today is Mother’s Day!👩💐 Celebration means more than flowers and gifts. It stands for dignity, equity and care — ensuring every mother deserves a healthy life. #Sansure honors the quiet strength of mothers across the globe. Maternal and infant health has always been at the heart of Sansure’s mission. Every precise diagnostic solution we create, from genetic screening to reproductive health testing, is dedicated to caring for mothers, safeguarding newborns, and bringing health and peace to every family. We keep striving for a world where all mothers can access reliable precision healthcare, and no one is left behind. This year, let's take action to: ✅ Bridge the healthcare gap for maternal care ✅ Ensure equal access to early, accurate diagnostics ✅ Protect maternal and child health for generations to come Happy Mother's Day!💕 #MothersDay2026 #Sansure #MaternalHealth #IVD #HealthcareForAll

𝐇𝐚𝐧𝐭𝐚𝐯𝐢𝐫𝐮𝐬 𝐎𝐮𝐭𝐛𝐫𝐞𝐚𝐤!🚨 Recent #hantavirus cases linked to a cruise ship cluster in South America have renewed attention on Andes virus (#ANDV) surveillance and laboratory preparedness. Reference laboratory investigations have identified Andes virus (ANDV) as the outbreak-associated strain. 𝐖𝐡𝐲 𝐀𝐧𝐝𝐞𝐬 𝐕𝐢𝐫𝐮𝐬 𝐌𝐚𝐭𝐭𝐞𝐫𝐬? Andes virus is associated with Hantavirus Cardiopulmonary Syndrome (#HCPS) and is unique among hantaviruses due to documented limited person-to-person transmission among close contacts. Early symptoms are non-specific, making timely laboratory confirmation critical for clinical and public health decision-making. 𝐒𝐚𝐧𝐬𝐮𝐫𝐞 𝐌𝐨𝐥𝐞𝐜𝐮𝐥𝐚𝐫 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧🎯 Sansure provides a targeted real-time RT-PCR solution for Andes virus detection, supporting rapid and reliable laboratory testing. ✅ Specific ANDV detection ✅ High sensitivity and specificity ✅ Endogenous internal control  ✅ Compatible with major qPCR platforms  ✅ Integrated molecular testing workflow For Research Use Only (RUO) #AndesVirus #Hantavirus #HCPS #PCR #MolecularDiagnostics #PublicHealth #Sansure

𝐒𝐚𝐟𝐞 𝐁𝐥𝐨𝐨𝐝 𝐒𝐚𝐯𝐞𝐬 𝐋𝐢𝐯𝐞𝐬.❤ This #WorldRedCrossDay, guided by the theme Keeping Humanity Alive, we embrace compassion, solidarity and the selfless dedication of every blood donor. Every voluntary blood donation is a warm gift of life, while professional scientific testing stands as the strongest shield for blood safety. Every donation carries hope—but science makes it safe. At #Sansure, we guard blood safety with CE-certified NAT kits and systems: ✔ Ultra-sensitive performance ✔ Direct identification of HBV, HCV, HIV-1 & HIV-2 ✔ Complete subtype coverage ✔ Full automation solutions Precision for Safety, Commitment for Life. Together with the Red Cross mission, we turn kindness into trusted care. 👉 Explore our NAT Solution: https://lnkd.in/g-CqrnUc #WorldRedCrossDay #BloodSafety #IVD #HealthcareInnovation #Sansure

🚀 Big News: Sansure's 2025 Annual Report & 2026 Q1 Results Are Out! Strong fundamentals, steady growth, and global momentum—we're building on our strengths and ready for the next chapter. 💹Solid Business Growth 2025 revenue growth of 𝟏𝟐.𝟓𝟖% 𝐘𝐨𝐘 — a resilient foundation for sustained expansion. 🔬Innovation at Our Core R&D investment exceeded 𝐔𝐒𝐃 𝟒𝟒 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 in 2025, fueling a leading product portfolio and setting new standards in precision diagnosis and treatment. 🌍Global Expansion Accelerates Overseas revenue surged 𝟑𝟏.𝟔𝟑% 𝐘𝐨𝐘 in 2025. We're deepening local presence and building a robust global diagnostic ecosystem. Driven by innovation, trusted worldwide. This milestone reflects our commitment to advancing accessible, high-quality molecular diagnostics for all. ❤ 🔗 Learn more: https://lnkd.in/grahCw8E #Sansure #GlobalHealth #MolecularDiagnostics #Innovation #IVD

Proud to share that #Sansure Biotech represents Chinese innovation among the Top #PCR Technologies Companies globally.😎 Grateful for this recognition amid a fast-growing global PCR market (7.0% CAGR to USD 21.89B by 2030). We remain committed to advancing PCR innovation and delivering reliable #MolecularDiagnostics worldwide. Thank you for the continued trust and partnership. We're just getting started! 🙌 #Sansure #PCR #BiotechLeadership

𝐁𝐢𝐠 𝐧𝐞𝐰𝐬 𝐟𝐫𝐨𝐦 𝐌𝐮𝐧𝐢𝐜𝐡!🎉 Sansure shines at #ESCMID2026 ESCMID - European Society of Clinical Microbiology and Infectious Diseases, bringing cutting-edge healthcare solutions to the global community.🧬 From April 17 to 21, Sansure participated in the ESCMID held in Munich, Germany, showcasing its full-scenario solutions covering three core systems: #MolecularDiagnostics, #HematologyTesting, and #Immunoassays. 1️⃣ Molecular Diagnostic Solutions: Empower Hierarchical Diagnosis and Treatment to Improve Quality and Efficiency At the congress, Sansure presented diverse application scenarios ranging from central laboratories to primary healthcare, displaying core products such as Natch CS3 Plus, SLAN-48S, and iPonatic III Pro, along with the lastest achievements of its IVDR projects. 2️⃣ SUREXEVO's European Debut: A 12-Minute Diagnostic Revolution #SUREXEVO, the world's first AI-powered molecular POCT product, made its European debut after obtaining NMPA certification. Leveraging AI technology, it enables precise results in just 12 minutes. The Q-POC 2.0 platform was also unveiled, futher improving Sansure's innovative ecological layout. 3️⃣ New Products from Holding Companies Make European Debut: Collaborate to Support Inclusive Healthcare In addition, Sansure's holding companies — #WWHS and #HANPOCT — made their European debuts with NIR-1000 FIA and iMC Ge52e, focusing on accurate testing in primary care. With this, Sansure has formed a solid pattern of coordinated development across three systems: Hematology Testing, Immunoassays, and Molecular POCT. Sansure also has carried out testing and verification with many top European research institutions, and multiple projects on its reagent platform have successfully obtained EU IVDR certification, continuously enriching its product portfolio. During the congress, partners and end-users from Europe, LATAM, Africa and other regions visited Sansure's booth, highly recognizing the performance of Sansure's products and its professional service capabilities in on-site implementation. 😎 Moving forward, Sansure will continue to deepen its global layout and technological innovation, work hand in hand with global partners, and fulfill its vision of "𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐧𝐠 𝐋𝐢𝐟𝐞 𝐓𝐞𝐜𝐡 𝐅𝐨𝐫 𝐀𝐥𝐥" with more accessible and reliable life tech products and services. 👏 #Sansure #IVDR #ESCMID #GlobalHealthcare #MolecularDiagnostics #InVitroDiagnostics #hematology #immunoassay

As we mark STI Awareness Week, the numbers remind us why this conversation can’t wait. Globally, millions of new curable infections occur every year among adults, with over one million new cases every single day. 🫶🏻 Many STIs remain silent without obvious symptoms, making routine screening essential. Early detection not only protects individual health but also helps prevent long-term complications and breaks the chain of transmission in our communities. ✨ At Sansure, we’re dedicated to making that process faster and simpler. Our point-of-care solutions are designed to fit the realities of modern clinical settings—delivering ultra-fast results in as little as 25 minutes, supporting flexible wireless connectivity for busy labs, and streamlining workflows with high-throughput automation. 🔬 With a comprehensive menu covering key pathogens such as Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium, Trichomonas vaginalis, and more, we aim to empower healthcare providers with accurate answers when they’re needed most. Explore our range of STI products：https://lnkd.in/g_qaUTjk #STIweek #STIAwarenessWeek  #PublicHealth #SexualHealth #womenshealth #Healthcare #EarlyDetection #HealthAwareness

🌍 World Health Day – Together for Health. Stand with Science. This World Health Day, Sansure reaffirms our commitment to advancing global health through innovation. Guided by our mission — Innovating Life Tech For All — we believe that accessible, science-based solutions are key to building healthier communities everywhere. From high‑sensitivity molecular diagnostics enabling early disease detection, to portable POC platforms bringing precision testing to resource‑limited settings; from comprehensive respiratory panels empowering local hospitals to act fast, to reliable blood screening solutions safeguarding transfusion safety — we work hand in hand with partners around the world to turn science into action. Because health is not a privilege. It is a shared responsibility. Let's stand together, with science, for a healthier future. Learn more about us: www.sansureglobal.com #WorldHealthDay #Sansure #InnovatingLifeTechForAll

🌟 Join Sansure at ESCMID 2026 in Munich! We are thrilled to be returning to ESCMID Global! This year's event will take place in Munich, where we will showcase our latest innovations in the healthcare. As we continue to advance our mission, Innovating Life Tech For All, we look forward to connecting with industry leaders and partners to shape the future of global health. 📍 Booth F55 📅 April 17–21, 2026 📍 Messe München, Munich, Germany 🔬 What to expect: ✨ Explore our latest POC solutions with live product demonstrations 🤝 Meet our team to discuss tailored diagnostic strategies Let's connect in Munich and explore what's next in healthcare together. #ESCMID2026 #Sansure #MolecularDiagnostics #InfectiousDisease #POC #InnovatingLifeTechForAll

🌍 World Tuberculosis Day 2026: Yes! We Can End TB! 🫁 The numbers tell a sobering story: in 2024, tuberculosis claimed 1.23 million lives, with 10.7 million people falling ill. Behind each statistic is a person, a family, a community. Ending TB by 2035—the WHO’s clear goal—requires that diagnostics and care reach everyone, everywhere. At Sansure, we are dedicated to advancing this mission. Through our rapid, accurate TB testing solutions, we empower healthcare systems and frontline workers to detect TB early and break the chain of transmission, helping to save lives and curtail the spread of disease. Led by Countries. Powered by People. Together, we can end TB. #TBDay2026 #Sansure #GlobalHealth #YesWeCanEndTB